Published in Biomaterials on January 01, 2005
Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol (2007) 1.41
The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. Biomaterials (2009) 1.19
A novel flex-stretch-flow bioreactor for the study of engineered heart valve tissue mechanobiology. Ann Biomed Eng (2008) 1.15
On the biomechanical function of scaffolds for engineering load-bearing soft tissues. Acta Biomater (2010) 1.04
Quantification of the temporal evolution of collagen orientation in mechanically conditioned engineered cardiovascular tissues. Ann Biomed Eng (2009) 1.00
Effect of strain magnitude on the tissue properties of engineered cardiovascular constructs. Ann Biomed Eng (2007) 0.99
Role of cell-matrix interactions on VIC phenotype and tissue deposition in 3D PEG hydrogels. J Tissue Eng Regen Med (2013) 0.93
Scale-dependent fiber kinematics of elastomeric electrospun scaffolds for soft tissue engineering. J Biomed Mater Res A (2010) 0.92
Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Tissue Eng Part A (2010) 0.92
Interlayer micromechanics of the aortic heart valve leaflet. Biomech Model Mechanobiol (2013) 0.83
Tri-layered elastomeric scaffolds for engineering heart valve leaflets. Biomaterials (2014) 0.83
Periodontal ligament cells cultured under steady-flow environments demonstrate potential for use in heart valve tissue engineering. Tissue Eng Part A (2012) 0.82
Generating elastin-rich small intestinal submucosa-based smooth muscle constructs utilizing exogenous growth factors and cyclic mechanical stimulation. Tissue Eng Part A (2009) 0.81
Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering. J Healthc Eng (2012) 0.81
Laser microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering. J Biomed Mater Res A (2012) 0.80
Strain history and TGF-β1 induce urinary bladder wall smooth muscle remodeling and elastogenesis. Biomech Model Mechanobiol (2011) 0.80
Solute transport in cyclically deformed porous tissue scaffolds with controlled pore cross-sectional geometries. Tissue Eng Part A (2009) 0.78
Design and validation of a novel splashing bioreactor system for use in mitral valve organ culture. Ann Biomed Eng (2010) 0.78
A novel bioreactor for mechanobiological studies of engineered heart valve tissue formation under pulmonary arterial physiological flow conditions. J Biomech Eng (2014) 0.77
A triphasic constrained mixture model of engineered tissue formation under in vitro dynamic mechanical conditioning. Biomech Model Mechanobiol (2015) 0.77
Large strain stimulation promotes extracellular matrix production and stiffness in an elastomeric scaffold model. J Mech Behav Biomed Mater (2016) 0.77
A mathematical model for the determination of forming tissue moduli in needled-nonwoven scaffolds. Acta Biomater (2017) 0.75
Validation of a fluid-structure interaction model of solute transport in pores of cyclically deformed tissue scaffolds. Tissue Eng Part C Methods (2010) 0.75
Modeling the Role of Oscillator Flow and Dynamic Mechanical Conditioning on Dense Connective Tissue Formation in Mesenchymal Stem Cell-Derived Heart Valve Tissue Engineering. J Med Device (2013) 0.75
Thin films of SiO2 and hydroxyapatite on titanium deposited by spray pyrolysis. J Mater Sci Mater Med (2007) 0.75
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet (2007) 6.76
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab (2005) 4.65
Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation (2007) 4.36
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Early postoperative outcomes in a series of infants with hypoplastic left heart syndrome undergoing stage I palliation operation with either modified Blalock-Taussig shunt or right ventricle to pulmonary artery conduit. Pediatr Crit Care Med (2006) 2.77
Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation (2006) 2.68
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54
Engineering complex tissues. Tissue Eng (2006) 2.53
Synthesis, characterization, and cytocompatibility of elastomeric, biodegradable poly(ester-urethane)ureas based on poly(caprolactone) and putrescine. J Biomed Mater Res (2002) 2.49
Design and analysis of tissue engineering scaffolds that mimic soft tissue mechanical anisotropy. Biomaterials (2006) 2.40
Successful linking of the Society of Thoracic Surgeons adult cardiac surgery database to Centers for Medicare and Medicaid Services Medicare data. Ann Thorac Surg (2010) 2.24
Differential case ascertainment in clinical registry versus administrative data and impact on outcomes assessment for pediatric cardiac operations. Ann Thorac Surg (2012) 2.22
Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg (2009) 2.17
Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications. Biomaterials (2005) 2.08
Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation (2005) 2.05
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04
Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis (2004) 2.02
From stem cells to viable autologous semilunar heart valve. Circulation (2005) 1.94
Aortico-left ventricular tunnel: 35-year experience. J Am Coll Cardiol (2004) 1.93
Saddle shape of the mitral annulus reduces systolic strains on the P2 segment of the posterior mitral leaflet. Ann Thorac Surg (2009) 1.81
Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ Res (2006) 1.80
Finite element implementation of a generalized Fung-elastic constitutive model for planar soft tissues. Biomech Model Mechanobiol (2005) 1.76
Report of the 2010 society of thoracic surgeons congenital heart surgery practice and manpower survey. Ann Thorac Surg (2011) 1.76
Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76
Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am J Physiol Heart Circ Physiol (2005) 1.73
Modification of infarct material properties limits adverse ventricular remodeling. Ann Thorac Surg (2011) 1.72
The effects of aneurysm on the biaxial mechanical behavior of human abdominal aorta. J Biomech (2006) 1.71
On the biaxial mechanical properties of the layers of the aortic valve leaflet. J Biomech Eng (2007) 1.71
The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg (2003) 1.69
Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery. J Thorac Cardiovasc Surg (2008) 1.69
Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction. Circulation (2002) 1.67
Late pulmonary valve replacement in patients with pulmonary atresia and intact ventricular septum: a case-matched study. Ann Thorac Surg (2011) 1.60
Biaixal stress-stretch behavior of the mitral valve anterior leaflet at physiologic strain rates. Ann Biomed Eng (2006) 1.60
Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol (2004) 1.59
Successful linking of the Society of Thoracic Surgeons database to social security data to examine survival after cardiac operations. Ann Thorac Surg (2011) 1.58
Biodegradable poly(ether ester urethane)urea elastomers based on poly(ether ester) triblock copolymers and putrescine: synthesis, characterization and cytocompatibility. Biomaterials (2004) 1.57
Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. Biomaterials (2008) 1.57
The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg (2008) 1.56
Total anomalous pulmonary venous connection: an analysis of current management strategies in a single institution. Ann Thorac Surg (2005) 1.55
Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng (2009) 1.54
Characterization of the complete fiber network topology of planar fibrous tissues and scaffolds. Biomaterials (2010) 1.51
Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation (2012) 1.50
Congenital heart surgery databases around the world: do we need a global database? Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2010) 1.50
NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J Biol Chem (2002) 1.46
Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng (2002) 1.46
Collagen fiber disruption occurs independent of calcification in clinically explanted bioprosthetic heart valves. J Biomed Mater Res (2002) 1.46
Variation in outcomes for risk-stratified pediatric cardiac surgical operations: an analysis of the STS Congenital Heart Surgery Database. Ann Thorac Surg (2012) 1.46
Quality measures for congenital and pediatric cardiac surgery. World J Pediatr Congenit Heart Surg (2012) 1.45
A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg (2005) 1.45
Public reporting of healthcare data: a new frontier in quality improvement. Bull Am Coll Surg (2012) 1.45
An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction. J Am Coll Cardiol (2007) 1.44
Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial. J Thorac Cardiovasc Surg (2004) 1.44
Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation (2002) 1.43
Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol (2007) 1.41
Simulated bioprosthetic heart valve deformation under quasi-static loading. J Biomech Eng (2005) 1.40
Surgical management of neonatal atrioventricular septal defect with aortic arch obstruction. Ann Thorac Surg (2013) 1.39
Right ventricle to pulmonary artery conduit augmentation compared with replacement in young children. Ann Thorac Surg (2009) 1.39
Physician payment for 2007: a description of the process by which major changes in valuation of cardiothoracic surgical procedures occurred. Ann Thorac Surg (2007) 1.39
Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes (2002) 1.39
Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues. Biomaterials (2006) 1.38
Age dependency of the biaxial biomechanical behavior of human abdominal aorta. J Biomech Eng (2004) 1.36
Regional low-flow perfusion versus circulatory arrest in neonates: one-year neurodevelopmental outcome. Ann Thorac Surg (2006) 1.36
A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials (2003) 1.34
Early repair of hemitruncus: excellent early and late outcomes. J Thorac Cardiovasc Surg (2007) 1.33
The effects of cellular contraction on aortic valve leaflet flexural stiffness. J Biomech (2005) 1.33
Dynamic simulation of bioprosthetic heart valves using a stress resultant shell model. Ann Biomed Eng (2007) 1.32
Measurement of technical performance in congenital heart surgery: a pilot study. Ann Thorac Surg (2007) 1.27
Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: surgical experience from a single center. Ann Thorac Surg (2007) 1.27
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Eur J Cardiothorac Surg (2008) 1.26
Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng (2006) 1.26
Factors associated with prolonged recovery after the fontan operation. Circulation (2008) 1.25
Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine. FASEB J (2009) 1.23
Variation in congenital heart surgery costs across hospitals. Pediatrics (2014) 1.22
An experimentally derived stress resultant shell model for heart valve dynamic simulations. Ann Biomed Eng (2006) 1.22
A planar biaxial constitutive relation for the luminal layer of intra-luminal thrombus in abdominal aortic aneurysms. J Biomech (2006) 1.21
Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials (2005) 1.21
Fiber kinematics of small intestinal submucosa under biaxial and uniaxial stretch. J Biomech Eng (2006) 1.20
Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques. Circulation (2004) 1.19
The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. Biomaterials (2009) 1.19
In vitro dynamic strain behavior of the mitral valve posterior leaflet. J Biomech Eng (2005) 1.19
Collagen fiber alignment and biaxial mechanical behavior of porcine urinary bladder derived extracellular matrix. Biomaterials (2008) 1.19
Tissue-to-cellular level deformation coupling in cell micro-integrated elastomeric scaffolds. Biomaterials (2008) 1.18
Outcomes after bidirectional Glenn operation: Blalock-Taussig shunt versus right ventricle-to-pulmonary artery conduit. Ann Thorac Surg (2007) 1.17
Planar biaxial creep and stress relaxation of the mitral valve anterior leaflet. Ann Biomed Eng (2006) 1.17